Human MiR-4660 regulates the expression of alanine –glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis

ConclusionMiR-4660 is probably a new biomarker for mutation-negative idiopathic oxalosis by regulating the post-transcription ofAGXT, providing a potential treatment target of mutation-negative idiopathic oxalosis.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research